Column Group Management LP is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 6 open-market trades across 1 company since 2019, most recently 2020-07-28.
CIK 0001645340
6 open-market purchases totalling $2.4M since 2019, never a sale. Across 6 scored buys the stock is up 0.6% at ninety days, and 6.5 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NGM | 1,616,952 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2020-07-30 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 67% | 33% |
| Avg Move | +3.3% | +12.9% | +0.6% |
| Alpha | +1.3% | +8.6% | -6.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2020-07-28 | 2020-07-30 | $17.99 | $74K | +0.1% | -0.8% | -7.8% |
| NGM | BUY | 2020-07-22 | 2020-07-23 | $18.00 | $3K | +9.5% | +3.6% | -5.6% |
| NGM | BUY | 2020-04-03 | 2020-04-07 | $14.17 | $2.0M | +1.4% | +33.5% | +24.3% |
| NGM | BUY | 2019-11-04 | 2019-11-06 | $11.99 | $101K | +5.3% | +30.6% | +25.2% |
| NGM | BUY | 2019-08-01 | 2019-08-05 | $13.98 | $61K | +7.2% | +27.6% | -13.9% |
| NGM | BUY | 2019-04-08 | 2019-04-10 | $16.00 | $240K | -3.7% | -16.9% | -18.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.